Oncolytics Biotech (ONCY) Long-Term Investments (2009 - 2011)

Oncolytics Biotech (ONCY) has 3 years of Long-Term Investments data on file, last reported at $735681.0 in Q4 2011.

• On a quarterly basis, Long-Term Investments changed 0.0% year-over-year to $735681.0 in Q4 2011; TTM through Dec 2011 was $735681.0, a 0.0% change from a year earlier, with the FY2011 full-year figure at $735681.0, changed 0.0% from the prior year.
• Long-Term Investments for Q4 2011 stood at $735681.0, roughly flat from $735681.0 in the prior quarter.
• Over the last five years, Long-Term Investments for ONCY reached as high as $735681.0 in Q4 2010 and fell as low as $684000.0 in Q4 2009.
• Historically, Long-Term Investments has averaged $706149.0 across 3 years, with a median of $684000.0 in 2009.
• Across the five-year window, Long-Term Investments rose 7.56% in 2010 and changed 0.0% in 2011, its largest moves.
• Year by year, Long-Term Investments stood at $684000.0 in 2009, then advanced by 7.56% to $735681.0 in 2010, then changed by 0.0% to $735681.0 in 2011.
• Per Business Quant data, the three most recent Long-Term Investments figures were $735681.0 in Q4 2011, $735681.0 in Q1 2011, and $735681.0 in Q4 2010.